AIDS research and human retroviruses
Journal
Overview
publication venue for
-
Multiplex Analysis of Cytokines and Chemokines in Persons Aging With or Without HIV..
39.
2023
-
Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop Summary.
2023
-
Call for Papers: AIDS Research and Human Retroviruses.
2022
-
Call for Papers: AIDS Research and Human Retroviruses.
2021
-
Immunologic Change over 72 Weeks following Raltegravir- vs Efavirenz-based Therapy in HIV/HCV co-infected Individuals in Vietnam.
2021
-
Effects of Brief Adjunctive Metformin Therapy in Virologically Suppressed HIV-Infected Adults on Polyfunctional HIV-Specific CD8 T Cell Responses to PD-L1 Blockade..
37.
2020
-
Short Communication: Carotid Artery Plaque Burden in HIV Is Associated with Soluble Mediators and Monocytes..
36.
2020
-
Short Communication: Metformin Reduces CD4 T Cell Exhaustion in HIV-Infected Adults on Suppressive Antiretroviral Therapy..
36.
2020
-
White Blood Cell Counts, Lymphocyte Subsets, and Incident Diabetes Mellitus in Women Living With and Without HIV..
36.
2019
-
A Novel HIV-1 Nef Mutation in a Primary Pediatric Isolate Impairs MHC-Class I Downregulation and Cytopathicity..
36.
2019
-
Harvard HIV and Aging Workshop: Perspectives and Priorities from Claude D. Pepper Centers and Centers for AIDS Research..
35.
2019
-
C1q/TNF-Related Proteins, HIV and HIV-Associated Factors, and Cardiometabolic Phenotypes in Middle-Aged Women..
35.
2019
-
Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy..
35.
2018
-
Short Communication: Protective Efficacy of Broadly Neutralizing Antibody PGDM1400 Against HIV-1 Challenge in Humanized Mice..
34.
2018
-
Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus..
34.
2018
-
Genetic Variation of the Kinases That Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear Cells..
34.
2018
-
Ultra-Deep Sequencing Analysis on HIV Drug-Resistance-Associated Mutations Among HIV-Infected Individuals: First Report from the Philippines..
33.
2017
-
Association of Tuberculosis Status with Neurologic Disease and Immune Response in HTLV-1 Infection..
33.
2017
-
Plasminogen Activator Inhibitor-1 Predicts Negative Alterations in Whole-Body Insulin Sensitivity in Chronic HIV Infection..
33.
2017
-
The Risk of Cardiovascular Disease, Diabetes, Liver-Related Outcomes, and Death Over 10 Years in HIV/HCV-Coinfected Patients With and Without Steatosis..
32.
2016
-
The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype..
32.
2016
-
Short Communication: Virion Aggregation by Neutralizing and Nonneutralizing Antibodies to the HIV-1 Envelope Glycoprotein..
31.
2015
-
Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons..
31.
2015
-
Characterization of lipid composition and high-density lipoprotein function in HIV-infected individuals on stable antiretroviral regimens..
31.
2014
-
Albuminuria is associated with elevated acute phase reactants and proinflammatory markers in HIV-infected patients receiving suppressive combination antiretroviral therapy..
30.
2014
-
HIV infection in high school students in rural South Africa: role of transmissions among students..
30.
2014
-
Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda..
30.
2014
-
Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers..
30.
2014
-
The stem of vesicular stomatitis virus G can be replaced with the HIV-1 Env membrane-proximal external region without loss of G function or membrane-proximal external region antigenic properties..
30.
2014
-
Plasma monocyte chemoattractant protein-1 and tumor necrosis factor-α levels predict the presence of coronary artery calcium in HIV-infected individuals independent of traditional cardiovascular risk factors..
30.
2013
-
Human T cell lymphotropic virus type 1 infection among U.S. thalassemia patients..
29.
2013
-
Comparison of population and 454 "deep" sequence analysis for HIV type 1 tropism versus the original trofile assay in non-B subtypes..
29.
2013
-
Short communication: HIV type 1 subtype C variants transmitted through the bottleneck of breastfeeding are sensitive to new generation broadly neutralizing antibodies directed against quaternary and CD4-binding site epitopes..
29.
2013
-
Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion..
29.
2013
-
Short communication: HIV type 1 accumulates in influenza-specific T cells in subjects receiving seasonal vaccination in the context of effective antiretroviral therapy..
28.
2012
-
Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in mice..
28.
2011
-
A comparison of treatment eligibility for hepatitis C virus in HCV-monoinfected versus HCV/HIV-coinfected persons in electronically retrieved cohort of HCV-infected veterans..
27.
2011
-
Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals..
27.
2010
-
Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults..
27.
2010
-
Characterization of SIV in the oral cavity and in vitro inhibition of SIV by rhesus macaque saliva..
26.
2010
-
IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines..
26.
2010
-
Short communication: Methamphetamine treatment increases in vitro and in vivo HIV replication..
25.
2009
-
HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens..
25.
2009
-
High frequency of vitamin D deficiency in ambulatory HIV-Positive patients..
25.
2009
-
CD4+ T-cell decline after the interruption of antiretroviral therapy in ACTG A5170 is predicted by differential expression of genes in the ras signaling pathway..
24.
2008
-
Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection..
24.
2008
-
Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP..
23.
2007
-
Purified, proteolytically mature HIV type 1 SOSIP gp140 envelope trimers..
23.
2007
-
Clinical manifestations associated with HTLV type I infection: a cross-sectional study..
23.
2007
-
Construction and characterization of soluble, cleaved, and stabilized trimeric Env proteins based on HIV type 1 Env subtype A..
22.
2006
-
Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women..
22.
2006
-
Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma..
22.
2006
-
A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087..
21.
2005
-
Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307..
20.
2004
-
Evolutionary repair of HIV type 1 gp41 with a kink in the N-terminal helix leads to restoration of the six-helix bundle structure..
20.
2004
-
Entry inhibitors SCH-C, RANTES, and T-20 block HIV type 1 replication in multiple cell types..
19.
2003
-
Boosting of SIV-specific T cell responses in rhesus macaques that resist repeated intravaginal challenge with SIVmac251..
18.
2002
-
Human immunodeficiency virus type 1 Nef mediates activation of STAT3 in immature dendritic cells..
18.
2002
-
Dendritic cell amplification of HIV type 1-specific CD8+ T cell responses in exposed, seronegative heterosexual women..
18.
2002
-
Impact of antiretroviral therapy on decreasing hospitalization rates of HIV-infected patients in 2001..
18.
2002
-
HIV type 1 molecular clones able to use the Bonzo/STRL-33 coreceptor for virus entry..
17.
2001
-
Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals..
16.
2000
-
Parameters influencing measurement of the Gag antigen-specific T-proliferative response to HIV type 1 infection..
16.
2000
-
Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithm..
16.
2000
-
Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood..
14.
1998
-
Interactions of polyclonal and monoclonal anti-glycoprotein 120 antibodies with oligomeric glycoprotein 120-glycoprotein 41 complexes of a primary HIV type 1 isolate: relationship to neutralization..
14.
1998
-
Analysis of the interaction of antibodies with a conserved enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120..
14.
1998
-
Interaction of pregnancy steroid hormones and zidovudine in inhibition of HIV type 1 replication in monocytoid and placental Hofbauer cells: implications for the prevention of maternal-fetal transmission of HIV..
13.
1997
-
An investigation of the high-avidity antibody response to glycoprotein 120 of human immunodeficiency virus type 1..
13.
1997
-
Cytotoxic monocytes in the blood of HIV type 1-infected subjects destroy targeted T cells in a CD95-dependent fashion..
13.
1997
-
Determining neutralization serotypes of HIV type 1 by neural networks..
12.
1996
-
Differential production of interleukin 10 during human immunodeficiency virus infection..
12.
1996
-
Altered CD4 interactions of HIV type 1 LAI variants selected for the capacity to induce membrane fusion in the presence of a monoclonal antibody to domain 2 of CD4..
12.
1996
-
AIDS patient monocytes target CD4 T cells for cellular conjugate formation and deletion through the membrane expression of HIV-1 envelope molecules..
12.
1996
-
Effect of interleukin 12 on in vitro HIV type 1 replication depends on clinical stage..
12.
1996
-
Soluble CD4 induces the binding of human immunodeficiency virus type 1 to cells via the V3 loop of glycoprotein 120 and specific sites in glycoprotein 41..
12.
1996
-
Bathophenanthroline disulfonate and soluble CD4 as probes for early events of HIV type 1 entry..
11.
1995
-
Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies..
10.
1994
-
Antigenic variation in gp120s from molecular clones of HIV-1 LAI..
9.
1993
-
Detecting SIV gp120 and its interaction with soluble CD4 by ELISA..
9.
1993
-
Nonaffinity purification of recombinant gp120 for use in AIDS vaccine development..
9.
1993
-
A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody..
9.
1993
-
Soluble CD4 and CD4 immunoglobulin-selected HIV-1 variants: a phenotypic characterization..
9.
1993
-
Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4..
9.
1993
-
The reactivities of HIV-1+ human sera with solid-phase V3 loop peptides can be poor predictors of their reactivities with V3 loops on native gp120 molecules..
9.
1993
-
Effect of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage..
9.
1993
-
Identification of human immunodeficiency virus type 1 glycoprotein gp120/gp41 interacting sites by the idiotypic mimicry of two monoclonal antibodies..
9.
1993
-
Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins?.
8.
1992
-
Human immunodeficiency virus variants that escape cytotoxic T-cell recognition..
8.
1992
-
Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens..
8.
1992
-
The urge for an AIDS vaccine: perspectives from a developing country..
8.
1992
-
Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: use in topological analysis of a CD4 binding site..
8.
1992
-
Thermodynamic and kinetic analysis of sCD4 binding to HIV-1 virions and of gp120 dissociation..
8.
1992
-
Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro..
8.
1992
-
The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?.
7.
1991
-
Enhancement of soluble CD4-mediated HIV neutralization and gp 120 binding by CD4 autoantibodies and monoclonal antibodies..
6.
1990
-
Expression of HIV-1 gp120 and human soluble CD4 by recombinant baculoviruses and their interaction in vitro..
6.
1990
-
Prognostic significance of quantitative levels of HIV p24 binding capacity in HIV infection..
6.
1990
-
Levels of soluble CD8 antigen and circulating immune complexes in intravenous drug abusers: relationships to HIV antibody serology..
5.
1989
-
Sensitive ELISA for the gp120 and gp160 surface glycoproteins of HIV-1..
4.
1988
-
Prior Case of Resistance on Dolutegravir Plus Lamivudine Dual Therapy..
36.
2020
-
The Intimate Relationship Between CD4+ T Cell Morphology and HIV-1 Infection..
35.
2019
-
Human T-lymphotropic virus 1, breastfeeding, and antiretroviral therapy..
31.
2014
-
Inhibition of tat-activated, HIV-1 long terminal repeat-mediated gene expression by glucocorticoids..
9.
1993
-
Re: "Enhancement of HIV infection by cellulose sulfate," by Tao et al.
2009
-
Advances in AIDS Vaccine Development: 5th Annual meeting of the National Cooperative Vaccine Development Groups for AIDS. Chantilly, Virginia, August 30-September 3, 1992. Proceedings and abstracts.
1993
-
Update: HIV-1 gene nomenclature..
4.
1988
-
How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?
2011
-
V3: HIV's switch-hitter.
2005
-
The beta-chemokines, HIV type 1 second receptors, and exposed uninfected persons.
1996
-
Novel vaccination and antireceptor strategies against HIV.
1990
Identity
ISO Abbreviation
-
AIDS Res Hum Retroviruses
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)